The Economic Cost of Multiple Sclerosis in Sweden in 1994

Author： Henriksson F.   Jönsson B.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.5, 1998-05, pp. : 597-606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Burden of Multiple Sclerosis: A Systematic Review of the Literature

By Naci Huseyin  

PharmacoEconomics, Vol. 28, Iss. 5, 2010-05 ,pp. : 363-379

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Multiple Sclerosis in the UK, Germany and France

By Murphy N.  

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 607-622

Adis International

Access to resources Recommend Favorite

The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment

By Phillips C.J.  

CNS Drugs, Vol. 18, Iss. 9, 2004-01 ,pp. : 561-574

Adis International

Access to resources Recommend Favorite

Long Term Treatment of Multiple Sclerosis with Interferon- May Be Cost Effective

By Kendrick M.   Johnson K.I.  

PharmacoEconomics, Vol. 18, Iss. 1, 2000-07 ,pp. : 45-53

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis

By Lu Lanting   Pearce Hilary  

PharmacoEconomics, Vol. 30, Iss. 12, 2012-12 ,pp. : 1157-1171

Adis International

Access to resources Recommend Favorite